Ascentage Pharma Group International
NASDAQ: AAPG0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dajun Yang
- Employees
- 567
- Headquarters
- Suzhou, China
- IPO year
- 2025
- Market cap
- $1.6B
- Website
- https://www.ascentage.cn
Loading AAPG…
Loading profile data…Frequently asked questions about AAPG
What does Ascentage Pharma Group International (AAPG) do?
Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. The company is dedicated to discovering and advancing therapeutic solutions for a range of medical conditions, including various cancers, chronic hepatitis B virus (HBV) infections, and age-related ailments. A cor...
Where does AAPG trade?
Ascentage Pharma Group International (AAPG) trades on the NASDAQ Global Market.
What sector is AAPG in?
Ascentage Pharma Group International (AAPG) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Ascentage Pharma Group International?
Dajun Yang is the chief executive officer of Ascentage Pharma Group International (AAPG).
Where is Ascentage Pharma Group International headquartered?
Ascentage Pharma Group International is headquartered in China.
Does AAPG pay a dividend?
Ascentage Pharma Group International (AAPG) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AAPG go public?
Ascentage Pharma Group International (AAPG) completed its initial public offering in 2025.
Is AAPG an ADR?
Yes — AAPG is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Ascentage Pharma Group International reporting and dividends follow the underlying issuer.